Skip to content

Effect of a Test Meal on Satiation Hormones in Obese and Normal Weight Adolescents

Effect of a Test Meal on Satiation Hormones in Obese and Normal Weight Adolescents

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02020395
Enrollment
30
Registered
2013-12-24
Start date
2009-06-30
Completion date
2013-10-31
Last updated
2013-12-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endocrine System Diseases

Brief summary

The objective of this study is to examine ghrelin, amylin, glucagon and glucagon-like peptide (GLP)-1 responses to a test meal in lean and obese individuals.

Detailed description

The primary hypothesis is that obese adolescents have a disturbed balance of hormones associated with appetite regulation with less suppression of ghrelin and attenuated stimulation of GLP-1 secretion in response to meal intake compared to lean normal weight controls. A second aim of the study was to test which gastrointestinal peptides are most associated with insulin resistance.

Interventions

DIETARY_SUPPLEMENTtest meal (500 kcal)

whole wheat bread (68 g), butter(10 g), ham (25 g); chocolate cream (90 g); orange juice (200 mL)

Sponsors

University Children's Hospital Basel
CollaboratorOTHER
University Hospital, Basel, Switzerland
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
11 Years to 16 Years
Healthy volunteers
Yes

Inclusion criteria

* caucasian youth * pubertal Tanner stage x, y, or z

Exclusion criteria

* fasting plasma glucose \> 7.0 mmol/L * significant illness * taking medications

Design outcomes

Primary

MeasureTime frameDescription
Comparison of gastrointestinal peptide secretion in normal weight and obese adolescents2 hours blood samplingRelation of GLP-1 release to insulin secretion in normal weight and obese adolescents

Secondary

MeasureTime frameDescription
Association between gastrointestinal peptides and insulin release2 hours blood samplingDynamics of gastrointestinal peptide secretion including Tmax and Cmax

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026